Chen Lin

Chen Lin


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2025 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
LYLidan Yang
Lidan Yang
CLChen Lin
Chen Lin
Posterior Polar Cataract Combined with a cyst in the posterior segment of the vitreous has been described in one previous case report in 1946. Otherwise, there is no literature on this potential association. We describe a case of posterior polar cataract (PPC) combined with vitreous cysts. A 26-year-old man complained of shadowed vision in his right eye (20/20) since childhood. Slit lamp examination revealed a ring-shaped opaque plaque in the superior central part of the posterior capsule, attached to a pigmented vitreous cyst. AS-OCT demonstrated thin-walled and intact cystic structures behind and adjacent to the posterior lens capsule. The coexistence of PPC and vitreous cysts is a rare entity that requires careful evaluation and management. The presence of pigmentation and hemorrhages on the vitreous cyst seems to support the hypothesis that the vitreous cysts may be a cystic choristoma from the primitive hyaloid system.

21 May 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YCYingtong Chen
Yingtong Chen
XLXiaohan Li
Xiaohan Li
FZFuhua Zhong
Fuhua Zhong
XWXiaoya Wang
Xiaoya Wang
QWQiang Wang
Qiang Wang
CLChen Lin
Chen Lin
Aims and objectives: Retinoblastoma is the most common pediatric intraocular malignancy, although it remains a rare disease overall, yet the molecular targets and therapeutic vulnerabilities sustaining its most aggressive proliferative cell states remain incompletely defined. We aimed to identify actionable molecular regulators and potential therapeutic targets of malignant retinoblastoma progression using integrated single-cell transcriptomics and functional validation. Methods: We analyzed single-cell RNA sequencing data from 189,431 cells derived from 13 retinoblastoma tumors and 3 normal fetal retina samples. Data integration was performed using Harmony, followed by clustering, differential expression, and functional enrichment analyses. BIRC5 function was evaluated through overexpression and siRNA-mediated knockdown in retinoblastoma cell lines (Y79, WERI-Rb1), with assessment of proliferation, migration, invasion, and cell cycle–related proteins. Results: Clustering identified 10 retinal cell types, including cone precursor-like, cone-like, and two MKI67 + proliferative RB subpopulations enrichment of G2/M-phase genes and chromosomal instability pathways. MKI67 + cells2 displayed hyperactivated cell cycle genes, chromosomal instability, and mitotic checkpoint dysregulation. BIRC5 (survivin) was selectively overexpressed in 93.7% of MKI67 + cells2 (mean expression 1.733 ± 0.643), while minimally expressed in other retinal cells. Functional assays demonstrated that BIRC5 overexpression promoted proliferation, invasion, migration, and CCND1/CDK4 activation, while suppressing CHEK2–p21–mediated checkpoint control. Conversely, BIRC5 knockdown induced G1 cell cycle arrest and increased apoptotic activity, accompanied by activation of checkpoint pathways. Conclusion: This study defines BIRC5 as a cell-state–specific regulator of malignant proliferation in retinoblastoma and provides a mechanistic rationale for targeting survivin in highly proliferative tumor subpopulations.